IDH1 and glioblastoma: The majority of IDH mutations in GBM represent the replacement of arginine 132 by histidine in IDH1 [17], resulting in the loss of native enzymatic activity [18] as well as gain of the ability to produce 2-hydroxyglutarate [19].